Back to Stock Analysis
PHARMANIAGA$7081.KL
1 research article
PHARMANIAGA ($7081.KL) has 1 independent research article on RhinoInvestory, written by 1 analyst.
Heavy Moat InvestmentsBamSECBest Anchor Stocks
RhinoInsight
Acquired
Asian Century Stocks
41investmentsAtom FinanceFinChatBehind the Balance Sheet
Alessandro (Macro Strategist)
Equity Mates
AlluvialTradingviewCompound & Fire
Heavy Moat InvestmentsBamSECBest Anchor Stocks
RhinoInsight
Acquired
Asian Century Stocks
41investmentsAtom FinanceFinChatBehind the Balance Sheet
Alessandro (Macro Strategist)
Equity Mates
AlluvialTradingviewCompound & Fire
Heavy Moat InvestmentsBamSECBest Anchor Stocks
RhinoInsight
Acquired
Asian Century Stocks
41investmentsAtom FinanceFinChatBehind the Balance Sheet
Alessandro (Macro Strategist)
Equity Mates
AlluvialTradingview1 research article
PHARMANIAGA ($7081.KL) has 1 independent research article on RhinoInvestory, written by 1 analyst.
Asian Dividend Stocks
Asian Century StocksBaFin - Managers' transactions
Alluvial
Heavy Moat Investments
41investments
Equity Mates
RhinoInsightBenzinga
The Wolf of Harcourt Street
Alessandro (Macro Strategist)AlphaSenseKoyfinTradingviewAmibroker
Acquired
Asian Dividend Stocks
Asian Century StocksBaFin - Managers' transactions
Alluvial
Heavy Moat Investments
41investments
Equity Mates
RhinoInsightBenzinga
The Wolf of Harcourt Street
Alessandro (Macro Strategist)AlphaSenseKoyfinTradingviewAmibroker
Acquired
Asian Dividend Stocks
Asian Century StocksBaFin - Managers' transactions
Alluvial
Heavy Moat Investments
41investments
Equity Mates
RhinoInsightBenzinga
The Wolf of Harcourt Street
Alessandro (Macro Strategist)AlphaSenseKoyfinTradingviewAmibroker
Acquired